Critical Care Panel (June 9, 2021)

Needs Statement

General, plastic, thoracic, vascular, cardiothoracic, abdominal transplantation and surgical oncology physicians, residents, fellows and medical students need to be regularly updated on novel therapies, as well as advances in surgical care and clinical practices that will aid them in treating a variety of surgical procedures to increase the patient care experience and improve practice efficiency.

Educational Objectives

"Updated Definitions of Sepsis"

At the conclusion of the session, the participants should be able to:

• Review the new definition and diagnostic criteria for sepsis.
• Discuss the components of the sequential organ failure assessment (SOFA) score.
• Describe the mainstays of the sepsis bundles.

"Advances in Sepsis Monitoring in the SICU"

At the conclusion of the session, the participants should be able to:

• Discuss the limitations of central venous pressure in resuscitation.
• Demonstrate greater understanding of the methods for assessing preload dependence.
• Explain the utility of bedside ultrasound in resuscitation.

"Latest Vasopressor Strategies for Septic Shock"

At the conclusion of the session, the participants should be able to:

• Compare vasopressor dosages between different vasopressors.
• Identify pharmacological adjuncts to mitigate vasoplegic shock.
• Describe a rational escalation of vasopressors in septic shock.

"Sepsis and the COVID-19 Experience"

At the conclusion of the session, the participants should be able to:

• Describe the systemic response to sepsis and COVID-19.
• Identify the limitations of evidence-based practices related to sepsis and COVID-19.
• Prepare for future unexpected challenges by applying knowledge gained from the pandemic.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

June 1, 2021 through June 30, 2023. Original release date: June 1, 2021.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.